Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

More On SUNPHARMA.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

-NSE

974.80 Up 2.90(0.30%) 1:17AM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2010Mar 30, 2009Mar 30, 2008Mar 30, 2007
Total Revenue 39,040,000   42,723,000   33,565,000   21,359,000  
Cost of Revenue13,890,000  11,189,000  8,986,000  7,292,000  
Gross Profit 25,150,000   31,534,000   24,580,000   14,067,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses28,673,000  25,134,000  18,973,000  15,442,000  
Operating Income or Loss 10,366,000   17,590,000   14,593,000   5,917,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes10,366,000  17,590,000  14,593,000  5,917,000  
Interest Expense -   -   -   -  
Income Before Tax -   -   -   -  
Income Tax Expense679,000  712,000  485,000  (67,000)
Minority Interest41,000  (603,000)(640,000)(559,000)
Net Income From Continuing Ops13,511,000  18,177,000  14,869,000  7,843,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 13,511,000   18,177,000   14,869,000   7,843,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.